Audion Therapeutics BV, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs and delivery technologies for the treatment of diseases affecting the ear, including hearing loss. The company’s hearing loss small molecule drug discovery program focuses on inner hair cell regeneration. Its IP portfolio includes new molecules, delivery systems, and drug discovery tools for hearing and hearing loss research. The company was founded in 2008 and is based in Amsterdam, the Netherlands.